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The pathogenetic mechanism of the mitochondrial
tRNALeu(UUR) A3243G transition associated with the mi-
tochondrial myopathy, encephalopathy, lactic acidosis,
and stroke-like episodes (MELAS) syndrome has been
investigated in transmitochondrial cell lines con-
structed by transfer of mutant mitochondrial DNA
(mtDNA)-carrying mitochondria from three genetically
unrelated MELAS patients or of isogenic wild-type
mtDNA-carrying organelles into human mtDNA-less
cells. An in vivo footprinting analysis of the mtDNA seg-
ment within the tRNALeu(UUR) gene that binds the tran-
scription termination factor failed to reveal any differ-
ence in occupancy of sites or qualitative interaction
with the protein between mutant and wild-type mtD-
NAs. Cell lines nearly homoplasmic for the mutation
exhibited a strong (70–75%) reduction in the level of
aminoacylated tRNALeu(UUR) and a decrease in mito-
chondrial protein synthesis rate. The latter, however,
did not show any significant correlation between syn-
thesis defect of the individual polypeptides and number
or proportion of UUR codons in their mRNAs, suggest-
ing that another step, other than elongation, may be
affected. Sedimentation analysis in sucrose gradient
showed a reduction in size of the mitochondrial poly-
somes, while the distribution of the two rRNA compo-
nents and of the mRNAs revealed decreased association
of mRNA with ribosomes and, in the most affected cell
line, pronounced degradation of the mRNA associated
with slowly sedimenting structures. Therefore, several
lines of evidence indicate that the protein synthesis de-
fect in A3243G MELAS mutation-carrying cells is mainly
due to a reduced association of mRNA with ribosomes,
possibly as a consequence of the tRNALeu(UUR) amino-
acylation defect.
Mutations in tRNA genes constitute a large proportion,
;75% (1), of the disease-causing mutations identified so far in
human mitochondrial DNA (mtDNA).1 Investigations of their
pathogenetic mechanisms can provide important information
on mitochondrial protein synthesis and other aspects of mito-
chondrial biogenesis. Among such studies are those on the
A8344G mutation in tRNALys, which causes myoclonic epilepsy
and ragged red fiber syndrome (MERRF) (2), and those on the
T7445C mutation in the nucleotide immediately adjacent to the
39-end of the tRNASer(UCN) gene, which is associated with deaf-
ness (3, 4). The former tRNA mutation causes premature ter-
mination of translation, most likely due to a tRNALys amino-
acylation deficiency (5), while the latter mutation produces a
reduction in the level of tRNASer(UCN), due to a defect of pre-
cursor processing, that also reduces the level of the co-tran-
scribed ND6 mRNA (6). Protein synthesis in mitochondria with
the latter mutation is presumably also affected at the level of
elongation, but, rather than premature termination, there ap-
pears to be a pause in elongation, followed by a resumption of
synthesis.
The pathogenetic mechanism of the most extensively inves-
tigated tRNA gene mutation, the A3243G transition in the
tRNALeu(UUR) gene, which causes the MELAS encephalomy-
opathy (7), maternally inherited diabetes (8), or chronic pro-
gressive external ophthalmoplegia (9), is still unresolved, de-
spite the numerous investigations on this topic. The mutation
occurs in the middle of the binding site for the mitochondrial
transcription termination factor, mTERF (10) (Fig. 1a). In vitro
experiments have shown that the mutation does indeed reduce
the affinity of mTERF for the DNA (11) and cause a decrease in
the rate of termination of the rDNA transcription unit (12).
However, an analysis of mtDNA-less human cells repopulated
with mitochondria from MELAS patients (11, 13) did not reveal
any significant difference from the controls in the relative
steady-state levels of the two rRNA species, encoded upstream
of the termination site, and of the mRNAs encoded down-
stream. On the other hand, the mitochondrial protein synthesis
rate has been found to be decreased, as was the respiration
rate, in cell lines carrying the mutation (11, 13).
The protein synthesis defect has been proposed to be due to
stalling of translation by pseudoribosomes that have incorpo-
rated RNA 19, an incompletely processed transcript reported to
accumulate in A3243 mutant cells, in place of 16 S rRNA (14),
or possibly to defective posttranscriptional modification of the
tRNALeu(UUR) (15, 16). Yet others suggest that the mutant
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tRNA may cause mistranslation, leading to accelerated turn-
over of mitochondrial translation products (17, 18).
The results described in the present work do not fit a model
in which, in MELAS mutation-carrying cells, mitochondrial
translation is affected mainly at the level of elongation, either
prematurely terminating at or near UUR codons or pausing at
UUR codons and then resuming elongation. On the contrary,
they give strong support to a model in which the A3243G
mutation affects both the steady state level and the aminoacy-
lation efficiency of the tRNALeu(UUR) and, possibly as a conse-
quence of these changes, reduces the rate of assembly of mRNA
with ribosomes, with a resulting decrease in mitochondrial
translation rate.
EXPERIMENTAL PROCEDURES
Cell Culture—The cell lines used for these studies have been de-
scribed previously (11, 19, 20). 143B.TK2 is a human osteosarcoma-
derived cell line (ATCC CRL 8303); the 94I, 43B, 2SA, 2SC, 4H1, and
pT1 cell lines are mitochondrial transformants of an mtDNA-less (r0)
derivative of 143B.TK2, i.e. r0206 (21). The cell line pT1 is a r0206
transformant that carries the A8344G MERRF mutation in the mito-
chondrial tRNALys gene in nearly 100% of its mtDNA (19). 143B.TK2
cells and HeLa S3 cells in suspension were grown as described previ-
ously (21, 22). r0 cell transformants were grown in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum.
DNA Sequencing—For sequencing the tRNALeu(UUR) gene, the
mtDNA fragment between positions 3206 and 3728 was amplified,
using 20-nucleotide-long primers, by the polymerase chain reaction.
The product was then purified from an agarose gel and sequenced with
a primer corresponding to heavy (H)-strand nucleotides 3511–3491.
Similarly, the fragment of mtDNA between positions 11836 and 12553
that contains the tRNALeu(CUN) gene was amplified and then sequenced
with light (L)-strand primer L12080–12099 or H-strand primer
H12500–12479.
Determination of mtDNA Level—Total cellular DNA on slot blots was
hybridized with a 498-nucleotide probe for nuclear ribosomal DNA,
stripped, and then rehybridized with a 2537-nucleotide probe for mito-
chondrial ribosomal DNA as described (20).
In Vivo Footprinting of mtDNA—This was done as described previ-
ously (22, 23). Briefly, intact cells were treated with dimethyl sulfate
(DMS), which methylates unprotected guanines and adenines (24).
Total nucleic acids were then extracted and incubated with piperidine,
which cleaves the DNA preferentially at the methylated guanine resi-
dues (24). The DNA was subjected to multiple rounds of primer exten-
sion from a 32P-59-end-labeled H strand primer, as described previously
(23), and the final products were resolved on a sequencing gel.
Isolation of tRNAs and Quantification of in Vivo Aminoacylation—
Highly purified total mitochondrial tRNA was isolated as described
(25). Quantification of the steady state levels of individual mitochon-
drial tRNA species was done by RNA gel blot analysis as described (5),
using 32P-59-end-labeled oligonucleotides specific for tRNALeu(UUR),
tRNALys, tRNASer(UCN), tRNAGlu, and 12 S rRNA, as detailed previously
(6).
For quantification of the extent of aminoacylation of the tRNAs, a
rapid procedure for isolation of the mitochondrial fraction was used.
The tRNAs were extracted under acid conditions and then run on an
acid-urea 6.5% polyacrylamide gel to separate the charged and un-
charged tRNAs (5, 26). Quantification of band intensities was done by
PhosphorImager (Molecular Dynamics, Inc., Sunnyvale, CA) analysis.
Analysis of Mitochondrial Protein Synthesis Rates—mtDNA-encoded
proteins were labeled in 143B.TK2 and 43B cells in vivo for 30 min with
[35S]methionine in methionine-free medium in the presence of emetine,
as described previously, and the labeled protein gel patterns have been
published (11). For the present work, the mtDNA-encoded proteins in
2SA and 2SC cells were labeled for 20 or 40 min in the same manner,
using [35S]methionine (1175 Ci/mmol; Expre35S35S, NEN Life Science
Products) at 150 mCi/ml in Dulbecco’s modified Eagle’s medium minus
methionine, supplemented with 5% dialyzed fetal bovine serum. Ly-
sates of the labeled cells were analyzed by SDS-polyacrylamide gel
electrophoresis as described (27). The quantification of band intensities
was done by NIH Image analysis of optical gel scans of appropriately
exposed films.
To examine the stability of proteins synthesized in mitochondria, a
“pulse-chase” labeling protocol was used. 94I and 43B were exposed for
2 h to 0.2 mCi/ml of [35S]methionine in Dulbecco’s modified Eagle’s
medium minus methionine, supplemented with 10% dialyzed fetal bo-
vine serum and 100 mg/ml cycloheximide. The labeling medium was
then replaced with complete, nonradioactive medium, and the cells
were grown for 16 h at 37 °C before harvesting. For reference, other
samples were labeled for 2 h with [35S]methionine in the presence of
cycloheximide and then immediately harvested.
Analysis of Mitochondrial Ribosomes and Polysomes—For the anal-
ysis of mitochondrial polysomes, cells were labeled with [35S]methi-
onine as described (5) and mixed with 143B.TK2 cells that had been
labeled for 1 day with [5-3H]uridine in the absence of inhibitors (to
provide size markers for the sucrose gradients, as described below). The
mitochondrial fraction was then isolated and lysed with 2% Triton
X-100 as described (28) but in the presence of 5 mM dithiothreitol and 50
units/ml RNasin (Promega). The mitochondrial lysate was run on a
15–30% sucrose gradient (28) in 100 mM Tris-HCl, pH 6.7 (25 °C), 100
mM KCl, 10 mM MgCl2 (TKM buffer) in a Beckman SW41 rotor at 32,600
rpm for 190 min at 2 °C. Approximately 0.3-ml fractions from the
gradients were collected into tubes containing 10 ml of 2 mM dithiothre-
itol and 1 unit of RNasin (Promega), and a portion precipitated with
10% trichloroacetic acid in the presence of 50 mg of bovine serum
albumin. The precipitates were collected on Millipore HAWP filters,
and the radioactivity was counted. In a control experiment using puro-
mycin, the cells were incubated with 150 mg/ml puromycin (Sigma) for
10 min immediately following the 5-min [35S]methionine labeling pulse.
For the analysis of ribosomes and ribosomal subunits (28), cells were
treated for 20 min with 0.1 mg/ml actinomycin D to inhibit nuclear RNA
synthesis and then labeled for 1 h (unless otherwise stated) with 0.05
mCi/ml [5-3H]uridine (22 Ci/mmol; NEN Life Science Products) in the
continued presence of actinomycin D and pooled with ;10 times as
many unlabeled cells and with cells labeled with [2-14C]uridine in the
absence of inhibitors (see below). The mitochondrial fraction was then
isolated, lysed with 2% Triton X-100, and analyzed in the sucrose
gradient described above by running it in the SW41 rotor at 28,000 rpm
for 13.8 h at 2 °C.
As mentioned above, size markers for the sucrose gradients were
provided by the addition of [5-3H]uridine- or [2-14C]uridine-labeled
143B.TK2 cells to the cells that had been labeled for polysome or
ribosome analysis, respectively. In particular, 2.5 3 105 cells were
labeled for 1 day with 0.25 mCi/ml of [5-3H]uridine or of [2-14C]uridine
(60 mCi/mmol; ICN) in the absence of inhibitors. Under such labeling
conditions, the stable nucleus-encoded large and small subunit rRNAs
incorporate most of the radioactivity. Because the cytosolic ribosomes
and ribosomal subunits, with sedimentation constants 74, 60, and 40 S,
always contaminate the mitochondrial fraction, they are detectable in
the sucrose gradient profiles of the mitochondrial lysates by virtue of
their containing the long term 3H- or 14C-labeled nucleus-encoded
rRNAs.
For analysis of the RNAs in the various fractions of a sucrose gradi-
ent, pairs or triplets of fractions were pooled, and then 2 volumes of 50
mM Tris-HCl, pH 7.4, 0.3 M NaCl, 8 mM EDTA, 1% SDS, 150 mg/ml
proteinase K, and 10 mg/ml tRNA were added. The mixtures were
incubated at 37 °C for 30 min and then extracted twice with a 25:24:1
mixture of phenol/chloroform/isoamyl alcohol equilibrated with 10 mM
Tris-HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.5% SDS, precipitated
with ethanol, and finally dissolved in 10 mM Tris-HCl, pH 7.4, 1 mM
EDTA.
RNA Solution Hybridization Analysis—The RNAs from the desired
fractions were pooled and divided into five equal parts. An excess of
unlabeled DNA probe or mixture of probes was hybridized to each
aliquot of labeled RNA in 0.4 M NaCl, 10 mM Tris-HCl, pH 7.4, 1 mM
EDTA for 15 h at 60 °C. After digestion with RNases T1 (50 units/ml)
and A (40 mg/ml), the RNase-resistant radioactivity was determined as
described (29). The probes were as follows: for the detection of 16 S
rRNA, 12 S rRNA, and ND1 RNA, plasmid clones containing 805
nucleotide pairs of the 16 S rRNA gene, 800 nucleotide pairs of the 12
S rRNA gene, and 809 nucleotide pairs of the ND1 gene, respectively,
were used. To probe the RNAs downstream of the ND1 gene, an equimo-
lar mixture of clones containing sequences of the COI, COII, ATPase
8/ATPase 6, COIII, ND3, ND4L/ND4, ND5, and cytochrome b genes,
spanning 7424 nucleotide pairs of mRNA coding region was used. The
latter set of plasmid clones contained also the sequences of tRNAs
specific for Ser (both tRNAs), Asp, Lys, Glu, Arg, His, and Leu(CUN).
RNA Transfer Hybridization Analysis—This was done substantially
as described previously (11). The probes for ND1 mRNA, 16 S rRNA,
and 12 S rRNA were plasmids carrying the human mtDNA sequences
from position 2953 to 3311, from 1768 to 2573, and from 764 to 1466,
respectively. The probes for ND2 and COI mRNAs were plasmid inserts
that corresponded to the human mtDNA sequence from position 4431 to
5274, and from 6203 to 6910, respectively. All were labeled with
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[a-32P]dCTP or [a-32P]dATP by the random primer method (30).
Mathematical Analysis—Nonlinear curve fitting was done using the
Levenberg-Marquardt algorithm (KaleidaGraph software, Synergy).
RESULTS
Cell Lines—The cell lines 43B and 2SC, which carried the
A3243G mutation in nearly homoplasmic form (99 and 97%,
respectively) had been previously shown to have decreased
mitochondrial protein synthesis rates (;20 and ;50%, respec-
tively, of the wild-type rates, after a 30-min labeling pulse with
[35S]methionine) and markedly reduced respiration rates (,10
and ;18%, respectively, of the wild-type rates) (11). Another
mutant cell line, 4H1, that carried 98% mutant mtDNA (20),
was used in some of the analyses presented here. The
143B.TK2 cell line, and transmitochondrial cell lines 94I and
2SA all exhibited 100% wild-type DNA at position 3243 (11).
Cell lines 94I and 43B are isogenic except at position 3243, as
are the pair 2SA and 2SC.
The sequences of the tRNALeu(UUR) genes in 94I and 43B had
been previously shown (15) to be identical to the Cambridge
sequence (31) outside of position 3243. Polymerase chain reac-
tion amplification and sequencing of the tRNALeu(UUR) gene
from the 2SC and 4H1 cell lines (this work) also failed to reveal
any difference from the standard sequence. Furthermore, in
order to investigate the possible presence in the mutant cells of
a suppressor mutation in the other mitochondrial tRNALeu
gene, like the one at position 12,300 that has been recently
reported (32), the mitochondrial tRNALeu(CUN) gene of the 43B,
4H1, 2SA, and 2SC cell lines was polymerase chain reaction-
amplified and sequenced. No mutation at position 12,300 or at
any other position was found in this gene in any of the cell
lines.
The amount of mtDNA relative to nuclear DNA in the cell
lines 94I, 43B, 2SA, 2SC, and 4H1 was 129, 103, 130, 100, and
83%, respectively, of that in 143B.TK2 cells.
In Vivo Footprinting of mTERF mtDNA Binding Site—Pre-
vious evidence from in vitro experiments had shown that the
A3243G mutation decreased the binding of mTERF to mtDNA
and the efficiency of transcription termination (11, 12). In view
of the discrepancy of these results with the observed lack of any
effect of the mutation on the ratio of transcripts downstream to
those upstream of the termination site (11, 13), in the present
work in vivo footprinting experiments were carried out to de-
termine whether the A3243G mutation reduces the occupancy
of the mTERF binding sites or causes changes in the methyl-
ation interference pattern in living cells.
Fig. 1b shows the in vivo footprint of the mtDNA L strand of
the rDNA transcription termination region for several cell lines
that are wild-type at position 3243, namely HeLa, 143B.TK2,
94I, and 2SA, and two cell lines that carry the A3243G transi-
tion (in $97% of their mitochondrial genomes), 43B and 2SC.
The footprints of the protein can be seen in the lanes marked E
between positions 3232 and 3256, in agreement with data from
in vitro DNase I protection experiments (10) and from previ-
ously reported in vivo footprinting experiments (22). The region
protected from modification by DMS is the same in wild-type
and mutant cells. An analysis of the patterns from mutant
cells, after normalization to reference bands outside the
mTERF binding site, reveals protection of the new G residue at
position 3243. As the adjacent G at position 3242 is protected in
both wild-type and mutant cells, it is likely that protein pro-
tects position 3243 in control cells as well as in mutant cells,
but this effect is not detected because methylated A is not
efficiently cleaved by piperidine (24). The G at position 3244 is
affected in its in vivo methylation pattern, but inconsistently; it
FIG. 1. Effects of the A3243G muta-
tion on the in vivo footprinting pat-
tern of the mitochondrial rDNA tran-
scription termination region. a, the
portion of the human mtDNA sequence
that interacts with mTERF is indicated.
The A3243G mutation that causes
MELAS and other diseases is also shown.
b, footprint autoradiograms showing the
methylation interference pattern pro-
duced in vivo in the light strand mtDNA
sequence by the bound protein. C, control,
i.e. DNA purified from cells before modi-
fication with DMS and cleavage with pi-
peridine. E, experimental (i.e. modified
DNA extracted from intact cells exposed
to DMS and then treated with piperidine).
WT, wild type; MT, mutant. The filled
circles indicate sites that are hypermeth-
ylated because of the bound protein. The
open circles indicate sites that are pro-
tected from modification by the bound
protein. The tick with no circle indicates
the A at position 3243.
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is hypermethylated in 143B.TK2 and HeLa cells, in agreement
with published data (22), and also in 94I cells. By contrast, this
G is protected in 43B mutant cells. However, the modification
of methylation of this G is marginal in 2SA and 2SC cells. It is
not clear whether any significance is to be attributed to this
variable base modification.
Apart from the differences at 3243 and, possibly, at 3244,
there are no significant qualitative differences in the methyl-
ation interference pattern of the mitochondrial rDNA termina-
tion region between the mutants 43B and 2SC, on one hand,
and their isogenic controls, 94I and 2SA, respectively, or the
parental cell line 143B.TK2, on the other. Furthermore, a
densitometric analysis showed that, after correction for loading
differences, there is no significant consistent quantitative
change between mutant and control patterns in the nucleotide
protection or hypermethylation within the mTERF binding
segment in the tRNALeu(UUR) gene.
Amount and Specific Aminoacylation of Mutant
tRNALeu(UUR)—The transfer hybridization analysis of mito-
chondrial tRNAs in Fig. 2a shows that there is no obvious
difference in electrophoretic mobility between the mutant
tRNA and the wild-type species (compare, for example, 2SA
and 2SC). Correct processing of the mutant tRNALeu(UUR)
from its precursor had previously been shown by a structural
analysis of the 59- and 39-ends of mutant and wild-type
tRNALeu(UUR) (33) and confirmed recently by direct analysis of
the nucleotide composition (including modified nucleotides) of
the radioactively pure tRNA (15). On the other hand, the
steady state amount of tRNALeu(UUR), when normalized to the
values for tRNALys, tRNASer, tRNAGlu, and 12 S rRNA, appears
to be reduced in 43B to 47, 35, 42, and 60%, respectively (mean
46%), of the isogenic control, 94I; in 2SC to 41, 32, 42, and 69%
(mean 46%) of the isogenic control, 2SA; and in 4H1 to 63, 55,
46, and 86% of the control average (mean 62%) (Fig. 2c).
The proportion of tRNA that is charged with amino acid in
vivo was determined for several mitochondrial tRNAs (Fig. 2b),
using acid conditions for RNA extraction and gel electrophore-
sis (26). The cell lines carrying the A3243G mutation showed a
specific marked reduction in the efficiency of charging of
tRNALeu(UUR), which was only 46% in 43B, as compared with
85% in 94I, 51% in 2SC, as compared with 82% in 2SA, and 41%
in 4H1 (Fig. 2d). By contrast, the tRNALys, transcribed
FIG. 2. RNA transfer hybridization analysis of tRNAs isolated from 94I and 2SA control cells and 43B, 2SC, and 4H1 mutant cells.
a, the total mitochondrial tRNAs from the indicated sources were fractionated on a polyacrylamide gel, transferred onto a ZetaProbe nylon
membrane (Bio-Rad), and hybridized successively with the indicated three specific probes. b, left panel, the total tRNA from the indicated sources
was isolated under conditions that preserved the amino acid-tRNA bond, fractionated on an acid-urea gel, transferred onto nylon membranes, and
hybridized successively with the indicated specific probes. b, right panel, samples of total tRNA from 4H1 cells, isolated as described above, were
electrophoresed either untreated or after deacylation by exposure to 65 °C at pH 8 for 10 min (DA) and then blotted and hybridized with the probe
for tRNALeu(UUR). c, total amount of tRNALeu(UUR) per cell; d, proportion in vivo of the aminoacylated tRNALeu(UUR); e, amount per cell of charged
tRNALeu(UUR) in control cell lines 94I and 2SA and in mutant cell lines 2SC, 43B, and 4H1. Error bars represent one S.E.
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from the H strand, like tRNALeu(UUR), and the tRNASer(UCN),
transcribed from the L strand, were charged at normal levels in
the A3243G mutant cells (Fig. 2b). By combining the decrease
in the amount per cell of total tRNALeu(UUR) and the reduction
in the efficiency of aminoacylation of this tRNA in mutant cells,
the absolute levels of total aminoacylated tRNALeu(UUR) per cell
in the different cell lines were calculated to be, in 43B and 2SC,
only 25 and 29%, respectively, relative to the levels found in the
corresponding control cell lines 94I and 2SA, and in 4H1 the
level was found to be 31% of the average level in the controls
(Fig. 2e).
Testing of Models of Elongation Defect in Mitochondrial Pro-
tein Synthesis in Mutant Cells—Previous work (11) had shown
that 43B cells exhibited, after a 30-min [35S]methionine pulse,
an ;80% decrease in the average rate of labeling of the various
mtDNA-encoded polypeptides, relative to their average rate of
labeling in the control cell lines. In Fig. 3a, the 30-min labeling
data for the individual polypeptides in 43B relative to the
values for 143B.TK2 are plotted versus the number of leucine
(UUR) codons and tested for fit to a model according to which
each leucine (UUR) codon reduces by a certain percentage the
probability of elongation continuing at that site. The equation
describing this “premature termination” model, previously pro-
posed for the tRNALys A8344G mutation associated with the
MERRF syndrome (5), is of the form y 5 y0zA
n, where y is the
rate of synthesis of a given polypeptide in the mutant cells
relative to its synthesis rate in wild-type cells, y0 is the theo-
retical relative rate of polypeptide synthesis for a reading
frame that has no UUR codons, A is the average probability
that chain elongation continues at each UUR codon, and n is
the number of UUR codons in the reading frame. It should be
noted that, in the above equation, the rate of synthesis, y, refers
to rate of production of a completed polypeptide chain, not to
elongation rate. If the premature termination defect were to
fully explain the decrease in synthesis rates, y0 would be equal
to 1.0. A curve-fitting algorithm was applied, setting y0 at 1.0
and optimizing the value for A. As shown in Fig. 3a, the best
curve for the 43B protein synthesis data exhibits a rather poor
fit, the coefficient of determination, R2, being ,0.10. In agree-
ment with the conclusion that the relative labeling data of the
individual polypeptides in 43B cells do not fit a model of pre-
mature termination of translation, no truncated polypeptides,
as were found in MERRF mutation-carrying cells (5), or labeled
bands corresponding to possible peptidyl-tRNAs were observed
in the patterns of newly synthesized mitochondrial translation
products.
The labeling data of the mitochondrial translation products
in 43B cells, relative to those for 143B.TK2, when plotted
versus the proportion of UUR codons in the reading frames,
also do not appear to fit an alternative model, the “transient
pause” model, according to which the ribosome stalls at each
UUR codon for a certain time and then resumes elongation in
the proper frame. The equation describing that model, which
was previously proposed for the T7445C mutation affecting
tRNASer(UCN) synthesis and associated with sensorineural
deafness (6), is of the form y 5 y0/((1 2 x) 1 dfzx), where x is the
proportion of codons in a reading frame that are UUR, and df is
the delay factor, i.e. the elongation time at a UUR codon di-
vided by the average elongation time at all the other codons. If
we set y0 to 1.0, assuming that only the transient pause at UUR
codons determines the decrease in protein synthesis rates, and
we optimize the value for df, the equation describing this model
that best conforms to the data defines also a very poorly fitting
curve (R2 , 0.10) (Fig. 3b). Subsequently, an analysis of the
relative rate of synthesis of the various polypeptides versus the
number or proportion of UUR codons in 43B mutant cells
relative to 94I wild-type cells confirmed the results obtained
with 43B cells relative to 143B.TK2 wild-type cells (data not
shown).
In 2SC cells, which contained ;97% mutant mtDNA (11),
mitochondrial protein synthesis was somewhat less affected
than in 43B cells. In particular, in these cells, the mitochon-
drial translation products were labeled on the average, after a
20- or 40-min [35S]methionine pulse, ;20 or ;40%, respec-
tively, less than in 2SA cells. Again, the relative labeling data
for the individual polypeptides do not show any significant
FIG. 3. Relationship between rela-
tive rate of synthesis of the individ-
ual mitochondrial translation prod-
ucts and UUR content of their
mRNAs in mutant cells. The rates of
labeling of individual mtDNA-encoded
polypeptides in 43B (a and b) or 2SC (c
and d) mutant cells, after a 30-(a and b)
and 40-min (c and d) pulse with [35S]me-
thionine, expressed relative to the corre-
sponding control rates in 143B.TK2 or
2SA cells, are plotted against the number
of UUR codons in the corresponding read-
ing frames (a and c) or against the pro-
portion of the UUR codons of the reading
frames (b and d). The best fitting curves
defined by equations for a premature ter-
mination model (a and c) or a transient
pause model (b and d) are drawn in gray.
R2, the coefficient of determination, is a
measure of how well the data fit the
curve. WT, wild-type.
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correlation with either the number or proportion of UUR
codons in their reading frame, which would conform, respec-
tively, to the premature termination of translation model (R2 ,
0.10) or the transient pause model (R2 , 0.10). This is shown in
Fig. 3, c and d, for the 40-min labeling data. Very similar
results were obtained for the data from a 20-min [35S]methi-
onine pulse. No abnormal [35S]methionine-labeled bands rep-
resenting possible truncated polypeptides or peptidyl-tRNAs
were observed in the mitochondrial translation patterns from
2SC cells, even after a 20-min pulse, supporting the conclusion
that no premature termination of translation occurs in these
cells either.
As shown in Fig. 3, the synthesis rates of the various
polypeptides differed from one another in both 43B and 2SC
cells. However, these differences tended to be similar for most
of the mtDNA-encoded polypeptides in the two types of cells, as
appears most clearly for A6, A8, ND3, and ND6 in Fig. 3.
Stability of Newly Synthesized Mitochondrial Translation
Products—A pulse-chase labeling experiment was carried out
to assess the stability of the proteins synthesized in mitochon-
dria of 43B mutant and 94I wild-type cells, with the rationale
that generalized instability of the proteins from mutant cells
could point to a misincorporation of amino acids resulting from
the tRNALeu(UUR) mutation. The gel patterns of cells pulse-
labeled for 2 h with [35S]methionine in the presence of cyclo-
heximide and then grown further in complete medium for 16 h
in the absence of [35S]methionine and cycloheximide were com-
pared with the gel patterns of cells harvested immediately after
a 2-h labeling pulse, correcting for differences in loading or
labeling, using as reference cytosolically synthesized proteins
that were labeled despite the presence of cycloheximide. The
analysis revealed that the majority of the proteins synthesized
in mitochondria of 43B cells (including COIII, ND1, ND2, ND3,
ND4, and ND6) were as stable as those synthesized in mito-
chondria of 94I cells (data not shown).
Reduced Polysome Size in Mutant Cells—The data presented
above on the lack of correlation between labeling rate of the
individual polypeptides and the UUR codon content of their
mRNAs suggested that the protein synthesis defect in cells
with the A3243G tRNALeu(UUR) mutation was not of the type
previously described for the tRNALys MERRF mutation nor of
that described for the T7445C mutation adjacent to the
tRNASer(UCN) gene. To gain more information on how the
A3243G mutation could affect protein synthesis in a way that
did not depend on the number or proportion of UUR codons, the
mitochondrial polysome size distribution, after sedimentation
in a sucrose gradient, was analyzed in lysates from the cell
lines investigated here. To visualize the monosomes and poly-
somes, the nascent polypeptide chains on mitochondrial ribo-
somes were labeled in the two mutant (43B and 2SC) cell lines
and in the two corresponding isogenic wild-type (94I and 2SA)
cell lines for 5 min with [35S]methionine in the presence of
emetine (at a concentration previously shown to inhibit all
cytosolic polysome labeling (28)). The [35S]methionine-labeled
cells were mixed, to provide size markers, with cells that had
been long term labeled with [5-3H]uridine in the absence of
inhibitors, and Triton X-100 lysates of the mitochondrial frac-
tions were then run in sucrose gradients. As illustrated in Fig.
4a, all of the [5-3H]uridine profiles showed the expected three
peaks corresponding to the cytosolic 74 S ribosomes and 60 and
40 S ribosomal subunits. Furthermore, all of the sucrose gra-
dient patterns (except 94I puromycin) showed the 35S-labeled
mitochondrial monosomes (28) sedimenting just ahead of the
cytosolic large ribosomal subunit 60 S marker and, therefore,
clearly sedimenting faster than the expected position of the
mitochondrial 55 S ribosomes (34). Peaks corresponding to
disomes (;80 S) and, in wild-type cell patterns, also trisomes
(;105 S) were apparent as well; larger polysomes were less
well separated. That these profiles did indeed represent mono-
somes and polysomes was demonstrated by the observation
that the [35S]methionine label was released from the pulse-
labeled structures by puromycin (Fig. 4a). A comparison of the
profiles from mutant cells, 43B and 2SC, with those from the
respective isogenic wild-type cells (94I and 2SA) clearly re-
vealed a change in the distribution of polysomes toward a
smaller size in the mutant cells and, in 43B, a much reduced
labeling of monosomes and disomes. These results indicated
that the number of ribosomes per mRNA molecule was de-
creased in mutant cells.
Unusual mRNA-containing Structures in Mitochondria of
Mutant Cells—There were two possible explanations for the
observation of smaller mitochondrial polysomes in the A3243G
mutation-carrying cells. The first explanation was premature
translation termination and release of incomplete polypeptides
or peptidyl-tRNAs at or near UUR codons. However, the ab-
sence of abnormal [35S]methionine-labeled bands, even after
pulses as short as 20 min, in the numerous patterns of newly
synthesized mitochondrial translation products analyzed in the
present work appeared to argue against this possibility. The
second explanation was that the rate of loading of ribosomes
onto the mRNAs was decreased in mutant cells. To investigate
the latter possibility, an analysis of the distribution in a su-
crose gradient of the newly assembled mitochondrial ribosomes
and ribosomal subunits was carried out. For these experi-
ments, mitochondrial RNA was labeled in different cell lines for
1 h with [5-3H]uridine in the presence of actinomycin D to
inhibit nuclear RNA synthesis, and Triton X-100 lysates of the
mitochondrial fractions were then run on sucrose gradients.
Fig. 4b shows that, in the patterns from the control cell lines
94I and 2SA, the mitochondrial monosomes, migrating slightly
ahead of the cytoplasmic 60 S marker, the large mitochondrial
ribosomal subunit, migrating at 39 S, and the small mitochon-
drial ribosomal subunit, migrating at 28 S (34), were clearly
separated. By contrast, in the profile from the mutant cell line
43B, the 28 S peak was unexpectedly obscured by a large peak
formed by heterogeneous material centered at ;25 S. A major
part of the pulse-labeled RNA in this region was very unstable,
since the amount of 3H label in this peak, relative to the
amount of label in the ribosomal subunits, declined markedly
after 2- and 4-h pulses (Fig. 5).
The sedimentation profile of 3H-labeled RNA-containing
structures in the region of the mitochondrial ribosome and
ribosomal subunits derived from the mitochondrial lysate of
[5-3H]uridine pulse-labeled 2SC mutant cells was also abnor-
mal, pointing to an accumulation of heterogeneous material. In
this case, however, this material was faster sedimenting, mi-
grating between 28 and 60 S (Fig. 4b). This material obscured
in part the 28 and 39 S peaks, as is clear by comparison with
the profile from wild-type 2SA cells and the profile from
MERRF tRNALys mutation-carrying pT1 cells (Fig. 4b).
To identify the pulse-labeled RNA giving rise to the unusual
peak in the gradient of the 43B mitochondrial lysate, solution
hybridization assays using appropriate unlabeled probes were
carried out on RNA phenol-extracted from the 14–33 S region
of the sucrose gradient patterns from these cells and from
143B.TK2 wild-type cells. The results of these experiments
indicated that the excess of pulse-labeled material sedimenting
in the 14–33 S region of the sucrose gradient from 43B mutant
cells contained mainly mRNA sequences (Fig. 6). The absence
of accumulation of 3H-labeled ND1 mRNA presumably re-
flected the slowed processing of this RNA, evident from the
presence of the processing intermediate RNA 19 (13), which is
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more abundant in 43B cells than in 143B.TK2 cells (see below).
The experiments described above quantified newly synthe-
sized RNAs. However, the accumulation of mRNA sequences in
the 14–33 S region of the sucrose gradient from 43B cells could
be confirmed by an analysis of the steady state levels of RNAs
in this material isolated from a repeat experiment. Thus, in an
RNA transfer hybridization analysis of fractions which
spanned, as indicated in Fig. 7a, the portion of the sucrose
gradient that included the mitochondrial ribosomal subunits,
probes specific for ND1, ND2 (Fig. 7a), and COI mRNAs (not
shown) hybridized, in addition to the full-length mRNA species,
to abundant heterogeneous material, smaller than intact ND1,
or ND2, or COI mRNAs, respectively. The 12 S rRNA-specific
probe (Fig. 7a) and the 16 S rRNA-specific probe (not shown)
did not detect any smear of heterogeneously sized material in
the same region of the gradient. The rRNA probes did reveal,
however, a few discrete degradation products; these occurred
only in the same fractions that contained the full-length rRNA,
pointing to the occurrence of nicks in the isolated rRNAs. An
RNA transfer hybridization analysis carried out with the cor-
responding gradient fractions from a mitochondrial lysate of
143B.TK2 wild-type cells showed very little heterogeneously
sized material (Fig. 7b). In other experiments, an RNA transfer
hybridization analysis of the sucrose gradient fractions corre-
sponding to the mitochondrial ribosomal subunits from 94I
wild-type, and 2SC and pT1 mutant cells showed a markedly
lower amount of heterogeneously sized material hybridizing
with ND1 or ND2 probes than was observed in the pattern from
43B cells (not shown).
The probe for ND1 mRNA also detected, in the RNA gel
blots of Fig. 7, a and b, RNA 19, the previously mentioned
incompletely processed H strand transcript of the 16 S rRNA,
tRNALeu(UUR), and ND1 genes (13). This RNA was found in
structures migrating slightly faster than the large mitochon-
drial ribosomal subunit. RNA 19 appeared to be more abundant
in the blot from the 43B mutant cells than in that from the
FIG. 4. Sucrose gradient profiles of mitochondrial polysomes and of ribosomes and ribosomal subunits in wild-type (WT) and
mutant cells. a, the black lines indicate the gradient profiles of [35S]methionine radioactivity, derived from 5-min pulse labeling of the nascent
polypeptide chains in mitochondria. The gray traces indicate the [5-3H]uridine radioactivity profiles derived from long term labeling of the cytosolic
ribosomes and subunits. Note the difference in scale of the y axis for the profile from 43B mutant cells. b, the black lines indicate the [5-3H]uridine
radioactivity profiles, derived from a 1-h pulse-labeling of mitochondrial RNA. The gray traces indicate the [2-14C]uridine profiles, derived from
long term labeling of the cytosolic ribosomes and subunits. The bottom of each gradient is at the left.
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143B.TK2 wild-type cells (Fig. 7b). The probe for 16 S rRNA
detected RNA 19 in the identical distribution in the gradient,
although RNA 19 was present in a very minor amount relative
to 16 S rRNA (not shown).
Distribution of rRNAs among Submitochondrial Struc-
tures—For the determination of the distribution in the sucrose
gradients of the two mitochondrial rRNA species, of the ND1
mRNA, and of RNA 19, an experiment was carried out in which
the mitochondrial lysates from 94I wild-type and 43B mutant
cells were fractionated in sucrose gradients, and the RNA was
extracted from fractions along the entire gradient, from the
pellet to the meniscus. RNA gel blot analysis was carried out on
these RNA preparations with probes for 12 S rRNA, 16 S rRNA,
and ND1 RNA. The hybridization signals observed with probes
for the 16 and 12 S rRNAs (blots not shown) were quantified,
and the data were grouped into rRNAs associated with mito-
chondrial polysomes and monosomes and rRNAs associated
with ribosomal subunits (Fig. 8). Also shown in Fig. 8 are data
from a similar experiment in which mitochondrial lysates from
2SC MELAS mutant cells and from pT1 MERRF mutant cells
were fractionated on sucrose gradients. One can see that a
major portion, 56%, of the 16 and 12 S rRNA species from 94I
wild-type cells migrated in the sucrose gradient with polysomes
and monosomes and that 35% migrated with ribosomal sub-
units. By contrast, there was a clear shift in the distribution of
the two rRNA species in the sucrose gradient patterns from the
MELAS mutation-carrying cells, so that only 47%, in 43B, and
45%, in 2SC, of these species were associated with monosomes
and polysomes, and 45 and 44%, respectively, were associated
with ribosomal subunits. Also to be noted in Fig. 8 is that, in
pT1 cells, which carry the MERRF tRNALys mutation, the
distribution of the rRNA species in the sucrose gradient is
almost identical to that of the 94I wild-type cells. The hybrid-
ization signal of RNA 19 with the 16 S rRNA probe, relative to
16 S rRNA, was ;1% in the gradients of the mitochondrial
lysates from 94I and 43B cells and ;2% in those from 2SC and
pT1.
Hybridization of the same blots with an ND1 probe (data not
shown), confirmed the presence of abundant degraded ND1
transcripts in the region of the sucrose gradient corresponding
to ribosomal subunits in the pattern from 43B mutant cells and
only minor amounts of such degraded transcripts in the region
of monosomes and polysomes. The pattern from 2SC cells
showed, as compared with that from control cells, a greater
proportion of ND1 mRNA in the region of ribosomal subunits
relative to that in the region of ribosomes and polysomes, as
would be expected for reduced ribosome loading. Furthermore,
we determined that the molar amount of ND1 RNA sequences
FIG. 5. Instability of RNA in 25 S structures. Mitochondrial RNA was labeled in vivo with [5-3H]uridine, in the presence of actinomycin D,
in 143B.TK2 wild-type cells and in 43B mutant cells for the indicated times. Mitochondrial lysates were fractionated in 15–30% sucrose gradients.
The gradient depicted in the lower right panel was run for 14.8 h at 32,600 rpm instead of 13.8 h at 28,000 rpm. The data in the different panels
have not been normalized. Filled circles, 3H cpm; open circles, 14C cpm.
FIG. 6. Proportion of 16 S rRNA, 12 S rRNA, mRNA, and ND1
mRNA in the 14–33 S region of the sucrose gradient after frac-
tionation of mitochondrial lysates from 143B.TK2 and 43B cells.
143B.TK2 wild-type and 43B mutant cells were labeled for 1 h with
[5-3H]uridine, mitochondrial lysates were fractionated, RNA was ex-
tracted, and samples were hybridized in solution with DNA probes
corresponding to various segments of the mitochondrial genome. Data
for RNase A- and T1-resistant radioactivity are plotted. pBSKS1, con-
trol hybridization carried out with empty vector pBluescript KS1.
Black bars, 143B.TK2 wild type; gray bars, 43B mutant.
Mitochondrial tRNALeu(UUR) Mutation 19205
associated with RNA 19 over the whole sucrose gradient, rela-
tive to that associated with all RNA species hybridizing to the
ND1 probe (i.e. RNA 19 and intact and degraded ND1 mRNA),
was ;9% in 43B cells, as compared with 12, 12, and 10% in 94I,
2SC, and pT1 cells, respectively.
DISCUSSION
Nature of the Mitochondrial tRNALeu(UUR) Defect—The de-
crease in level of total tRNALeu(UUR) observed in the mutant
cell lines (46–62% of the control values) could arise either from
decreased rate of formation from the corresponding primary
heavy strand transcript or from a decreased metabolic sta-
bility. Regarding the former possibility, the amount of RNA
19 (16 S 1 tRNALeu(UUR) 1 ND1), which may be a precursor
of tRNALeu(UUR), was greater in the 43B mutant transfor-
mant than in the 143B.TK2 parental cell line. However, it
was even greater in the 94I isogenic wild-type transformant,
indicating that processing of at least this putative precursor
molecule is not slowed by the mutation. Nor was there any
evidence of other molecules representing abnormally processed
tRNALeu(UUR) in the gel electrophoresis patterns. The alterna-
tive explanation for the reduced level of tRNALeu(UUR) (i.e. a
decreased metabolic stability) is a very likely possibility. As
recognized previously (13, 15), the A3243G mutation could very
well destabilize the tertiary structure of the molecule, making
it more susceptible to nucleolytic attack. The A3243G mutation
occurs at position 14 in the consensus structure of tRNA. The
base at this position is an invariant A in bacterial and cytosolic
eukaryotic tRNAs and is typically involved in the tertiary fold-
ing of classical tRNAs (35).
As concerns the explanation for the decrease in the amino-
acylation efficiency of the mutant tRNALeu(UUR), the A3243G
MELAS mutation does not occur in one of the two regions of
the tRNA structure that typically contain the identity ele-
ments, namely the acceptor stem and the anticodon (36–38).
Nevertheless, the mutation may directly affect binding of the
tRNALeu(UUR) to the synthetase, exacerbating the probable con-
tribution of the structural destabilization to the decrease in
aminoacylation rate (39–41).
In addition, the post-transcriptional methylation of the G at
nucleotide 3239 (position 10 in the consensus tRNA structure)
has been found to be reduced by 50% in 43B mutant cells
relative to 94I isogenic wild-type cells (15), and a deficiency of
the secondary modification of the uridine at the first position of
the anticodon has recently been reported in other A3243G
FIG. 7. RNA gel blot analysis of su-
crose gradient fractions of 43B and
143B mitochondrial lysates. a, por-
tions of sucrose gradient fractionation
profile of a mitochondrial lysate from 43B
MELAS mutant cells (a, upper panel) and
of a lysate from 143B.TK2 wild-type cells
(b, upper panel), both labeled for 1 h with
[5-3H]uridine. The middle and lower pan-
els show RNA transfer hybridization
analysis of fractions of the gradients
shown in the upper panels. Hybridization
was carried out with probes for ND1
mRNA, ND2 mRNA, and 12 S rRNA. In a,
sedimentation and hybridization patterns
from two overlapping portions of the gra-
dient are presented.
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mutant cells as well as in cells carrying the T3271C MELAS
mutation (16). In light of the evidence that has been presented
that post-transcriptional modifications of yeast tRNAAsp can
play a role in aminoacylation (42), it is possible that the un-
dermodifications mentioned above contribute further to the
reduced aminoacylation of the tRNALeu(UUR).
Yasukawa et al. (16) have shown that the mutant
tRNALeu(UUR) is aminoacylated with only leucine, thereby elim-
inating one possible route of misincorporation. The observa-
tions in the present work on the stability of mitochondrial
proteins tend to rule out misincorporation by other routes as
well.
Lack of Correlation between Individual Protein Synthesis
Rates and UUR Codon Content of mRNA—Previous work from
this laboratory has established that protein synthesis defects
due to some tRNA mutations can be explained by logical mod-
els of elongation defects. Thus, in the case of the mitochondrial
tRNALys A8344G mutation associated with the MERRF en-
cephalomyopathy, evidence for premature termination of
translation (or premature dissociation of ribosomes) was pro-
vided by 1) the presence of truncated translation products, 2)
the observation that polysomes were smaller than in control
cells, and 3) the finding that the residual rate of synthesis of
the individual polypeptides was an exponential function of the
number of lysine codons, as would be expected for premature
termination of translation (5). A description of an identical
model for a translation defect in an Escherichia coli mutant
had been previously published by Goldman (43), who predicted
and showed evidence for the same dependence of synthesis rate
on an exponential function of the number of codons for which
the charged tRNA was limiting.
In another instance, that of the T7445C transition affecting
the synthesis of tRNASer(UCN), evidence for the transient pause
model was provided by the absence of prematurely terminated
translation products and, especially, by the observation that
the residual rate of synthesis of the individual polypeptides
was not a function of the number of UCN codons but of the
proportion of these codons. Strikingly, the only exception to this
rule involved the ND6 polypeptide, whose lower than expected
rate of synthesis was shown to be due to a significant specific
decrease in its mRNA level, a decrease that resulted from the
effect of the T7445C mutation on RNA processing.
In A3243G mutation-carrying cells, the protein synthesis
data did not fit either of the models of elongation defect. The
lack of dependence of residual protein synthesis on UUR codon
content, discussed above, suggests that protein synthesis in
A3243G MELAS cells is limited by a mechanism operating
mainly at some step other than elongation. Furthermore, a
defect occurring primarily at the level of elongation that does
not lead to premature translation termination would be ex-
pected to produce larger polysomes in mutant cells, rather than
the observed smaller ones.
Evidence for Defective Polysome Formation—The mechanism
by which protein synthesis is affected by the A3243G mutation
in the present studies was suggested by the striking findings
pointing to a decrease in ribosome loading onto mRNA in the
mutant cell lines 43B and 2SC. This decrease in ribosome
loading was indicated 1) by the shift in polysome size toward
smaller polysomes (monosomes and disomes) in the absence of
prematurely terminated translation products, 2) by the appre-
ciable increase in proportion of 16 and 12 S rRNAs sedimenting
with free ribosomal subunits, and 3) by the increase in propor-
tion of ND1 mRNA sedimenting with free subunits in 2SC. In
contrast, no evidence was obtained of a shift of the two rRNA
species and of mRNA to the ribosomal subunit region of the
sucrose gradient of a mitochondrial lysate from the A8344G
tRNALys gene mutation-carrying pT1 cells, which also exhibit
smaller polysome size, but, in this case, as a result of prema-
ture translation termination.
A possible explanation for the observations listed above is
that the rate of initiation of mitochondrial translation is slowed
in MELAS mutant cells. One plausible mechanism to be con-
sidered for a defect in initiation and for defective polysome
formation in mutant cells is that shown to occur in the cytosol
of mammalian cells after amino acid starvation (44). Amino
acid starvation produced by omission of an essential amino acid
from the medium blocks initiation of protein synthesis by caus-
ing an increase in phosphorylated eIF-2 (45). Studies with
tRNA synthetase mutants and with specific inhibitors of ami-
noacylation have shown that uncharged tRNA in the cytosol of
mammalian cells can mediate the amino acid starvation effect,
blocking the formation of initiation complexes (46, 47).
Another possible mechanism of defective polysome formation
in A3243G mutation-carrying cells may involve an unidentified
important role of tRNALeu(UUR) in initiation of translation. The
evidence of heterogeneity in secondary modifications observed
in tRNALeu(UUR) (15, 16) and in its electrophoretic mobility (33)
is consistent with this tRNA having more than one function.
The multiplicity of functions of this tRNA gene may account
both for the large number of disease-causing mutations found
in this gene (1) and for the variability in phenotype associ-
ated with the A3243G mutation (1). It is interesting that the
FIG. 8. Bar graph distribution of steady state levels of mitochondrial rRNAs in sucrose gradient fractions from mitochondrial
lysates of 94I wild-type cells, 43B and 2SC MELAS mutant cells, and pT1 MERRF mutant cells. Mitochondrial lysates from the indicated
cell lines were fractionated on sucrose gradients, and the RNA from every fraction and from the pellets was extracted. RNA gel blot analysis was
carried out on the extracted RNAs, and the hybridization signals were quantified by PhosphorImager analysis. In all experiments, the amount of
16 and 12 S rRNAs migrating near the meniscus was #11% of the total and is not shown. Pol. & Mon., polysomes and monosomes; Rib. Sub.,
ribosomal subunits. Black bars, 16 S rRNA; gray bars, 12 S rRNA.
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tRNALeu(UUR) is one of the most abundant mitochondrial
tRNAs synthesized by the whole H strand transcription unit in
human cells (29). Strikingly, it is even more abundant than
mitochondrial tRNALeu(CUN), synthesized by the same tran-
scription unit, although the CUN codons are 6-fold more abun-
dant than the UUR codons. There are many examples of tRNAs
having functions other than the decoding of mRNA (48).
Finally, although there is evidence (33) that the 16 S rRNA
in mutant cells is processed correctly at the 39-end (i.e. at the
end most likely to be affected by the A3243G mutation), one
cannot exclude the possibility that alterations in secondary
modifications of 16 S rRNA may affect the association of the
large ribosomal subunit with the mRNA-small subunit
complex.
It is clear that further work is needed to clarify the source of
the defective association of mRNA with ribosomes detected in
the present work in MELAS mutation-carrying cells and the
mechanism whereby, in the more severely affected 43B cells,
the mRNA not assembled in polysomes becomes degraded.
Nature of the RNA Sedimenting at ;25 S—The heteroge-
neously sized [3H]uridine-labeled structures, with a median
sedimentation constant of ;25 S, in the sucrose gradients from
43B cells have been shown to contain an excess of mRNA,
relative to the corresponding region of control gradients. This
accumulation of mRNA in the 25 S region of the gradient
correlates with the strong decrease in polysome size in 43B
cells. These ;25 S structures may represent an RNA degrada-
tion complex similar to the 500-kDa degradosome that has been
described in E. coli and functions in normal mRNA turnover
(49). More recently, similar structures have been observed in
yeast mitochondria, where they function in intron turnover
(50), and in plastids, where they function in mRNA processing
(51). It is conceivable that more mRNA enters RNA-degrading
complexes in 43B mutant cells than in wild-type cells, because
of the severe defect of association of mRNA with polysomes in
this cell line.
Respiratory Phenotype Associated with the A3243G Muta-
tion—2SC mutant cells exhibit only a moderate decrease in
overall rate of mitochondrial protein synthesis (20–40%), yet
they have a low rate of O2 consumption, 0.86 fmol/min/cell, as
compared with 4.7 fmol/min/cell in the corresponding wild-type
transformant (2SA) (11). Low respiration rates or respiratory
enzyme rates in A3243G mutation-carrying cybrids have been
found by others as well (17, 18, 52). A plausible observation for
this phenomenon is the finding in the present work of a marked
decrease in the rate of synthesis of the ND6 subunit of NADH
dehydrogenase (complex I), which is in agreement with the
observations of Dunbar et al. (52). There is good evidence that
this enzyme complex is rate-limiting for respiration (53, 54). In
some MELAS patients (55–57), and also in A3243G mutant
transmitochondrial cell lines (52), a disproportionate deficiency
of complex I relative to the other respiratory complexes has
been reported. Furthermore, it has been shown that the ND6
subunit is essential for the assembly and activity of complex I
in mouse cells (58).
Proposed Model of Pathogenetic Mechanism—In summary,
previously published work and the evidence presented here
suggest the following model for the effects of the A3243G mu-
tation on mitochondrial protein synthesis and respiratory
chain function. The A3243G mutation causes an alteration in
the tertiary structure of the tRNALeu(UUR), a deficiency of
methylation of the G at nucleotide 3239 (15), and a deficiency of
modification of uridine at the first position of the anticodon
(16). As a consequence of the tertiary structure alteration or of
the reduced secondary modifications, or of both, the mutant
tRNALeu(UUR) is metabolically less stable and is charged to a
lesser extent by the leucyl-tRNA synthetase. The reduced level
of charged tRNA, or the reduced ratio of charged to uncharged
tRNA, or some other as yet unknown factor related to the
mutation then affects mRNA association with ribosomes, pos-
sibly through an effect on a mitochondrial translation initiation
factor, like IF-2mt (59), causing a general reduction in mito-
chondrial protein synthesis rate. In severely affected cells, the
degradation of mRNAs not associated with ribosomes becomes
apparent.
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